Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
argenx SE ha un obiettivo di prezzo consensuale di $773.55, basato sulle valutazioni degli ultimi 22 analisti. Il massimo è $1070 emesso da Guggenheim il settembre 18, 2025, mentre il minimo è $500 emesso da Stifel il giugno 24, 2024. Le ultime 3 valutazioni degli analisti sono state pubblicate da Morgan Stanley, Guggenheim e Truist Securities il ottobre 1, 2025, settembre 18, 2025 e settembre 15, 2025. Con un obiettivo di prezzo medio di $1009.33 tra Morgan Stanley, Guggenheim e Truist Securities, c'è un cambiamento implicito del 26.65% upside per argenx SE secondo queste ultime valutazioni degli analisti.
1calcolato in base alle valutazioni degli analisti
Buy Now | Get Alert | |||||||
---|---|---|---|---|---|---|---|---|
10/01/2025 | 30.5% | Morgan Stanley | $766 → $1040 | Maintains | Overweight | |||
09/18/2025 | 34.27% | Guggenheim | $1070 → $1070 | Reiterates | Buy → Buy | |||
09/15/2025 | 15.19% | Truist Securities | $700 → $918 | Maintains | Buy | |||
09/02/2025 | 11.3% | B of A Securities | $880 → $887 | Maintains | Buy | |||
08/26/2025 | 2.9% | Piper Sandler | $750 → $820 | Maintains | Overweight | |||
08/25/2025 | 6.66% | RBC Capital | → $850 | Initiates | → Outperform | |||
08/04/2025 | 4.15% | JP Morgan | $775 → $830 | Maintains | Overweight | |||
08/01/2025 | 34.27% | Guggenheim | $1060 → $1070 | Maintains | Buy | |||
08/01/2025 | -3.88% | Morgan Stanley | $700 → $766 | Maintains | Overweight | |||
08/01/2025 | -2.88% | HC Wainwright & Co. | $720 → $774 | Maintains | Buy | |||
07/31/2025 | -5.13% | Wells Fargo | $741 → $756 | Maintains | Overweight | |||
07/01/2025 | -9.65% | HC Wainwright & Co. | $720 → $720 | Reiterates | Buy → Buy | |||
06/24/2025 | -10.28% | Wedbush | $715 → $715 | Reiterates | Outperform → Outperform | |||
06/11/2025 | -10.28% | Wedbush | $715 → $715 | Reiterates | Outperform → Outperform | |||
06/11/2025 | -9.65% | HC Wainwright & Co. | $720 → $720 | Reiterates | Buy → Buy | |||
06/10/2025 | -9.65% | HC Wainwright & Co. | $720 → $720 | Reiterates | Buy → Buy | |||
05/13/2025 | -14.67% | Baird | $680 → $680 | Upgrade | Neutral → Outperform | |||
05/09/2025 | -11.16% | Oppenheimer | $704 → $708 | Maintains | Outperform | |||
05/09/2025 | 33.64% | Guggenheim | $1100 → $1065 | Maintains | Buy | |||
05/09/2025 | 0.76% | Citigroup | $796 → $803 | Maintains | Buy | |||
04/17/2025 | -0.12% | Citigroup | $681 → $796 | Maintains | Buy | |||
04/16/2025 | -10.28% | Wedbush | $715 → $715 | Reiterates | Outperform → Outperform | |||
04/11/2025 | -10.28% | Wedbush | $715 → $715 | Reiterates | Outperform → Outperform | |||
04/11/2025 | -9.65% | HC Wainwright & Co. | $720 → $720 | Reiterates | Buy → Buy | |||
04/08/2025 | -9.65% | HC Wainwright & Co. | $720 → $720 | Reiterates | Buy → Buy | |||
03/10/2025 | 38.03% | Guggenheim | $775 → $1100 | Maintains | Buy | |||
03/04/2025 | -14.67% | Baird | $650 → $680 | Maintains | Neutral | |||
02/28/2025 | -11.66% | Oppenheimer | $675 → $704 | Maintains | Outperform | |||
02/28/2025 | -7.02% | Wells Fargo | $723 → $741 | Maintains | Overweight | |||
02/28/2025 | -12.04% | Citizens Capital Markets | $696 → $701 | Maintains | Outperform | |||
02/28/2025 | -9.65% | HC Wainwright & Co. | $717 → $720 | Maintains | Buy | |||
01/14/2025 | -10.03% | HC Wainwright & Co. | $670 → $717 | Reiterates | Buy → Buy | |||
01/14/2025 | -12.16% | Truist Securities | $660 → $700 | Reiterates | Buy → Buy | |||
01/14/2025 | -12.66% | JMP Securities | $606 → $696 | Maintains | Market Outperform | |||
01/07/2025 | -9.02% | Piper Sandler | $620 → $725 | Maintains | Overweight | |||
01/03/2025 | -2.75% | Guggenheim | $665 → $775 | Maintains | Buy | |||
12/19/2024 | -9.28% | Wells Fargo | $639 → $723 | Maintains | Overweight | |||
11/21/2024 | -15.3% | Oppenheimer | $646 → $675 | Reiterates | Outperform → Outperform | |||
11/21/2024 | -11.41% | Evercore ISI Group | $675 → $706 | Maintains | Outperform | |||
11/20/2024 | -22.58% | HC Wainwright & Co. | $617 → $617 | Reiterates | Buy → Buy | |||
11/12/2024 | -12.54% | Wolfe Research | → $697 | Upgrade | Peer Perform → Outperform | |||
11/05/2024 | -10.28% | Scotiabank | $439 → $715 | Upgrade | Sector Perform → Sector Outperform | |||
11/04/2024 | -15.93% | JP Morgan | $640 → $670 | Maintains | Overweight | |||
11/01/2024 | -23.96% | JMP Securities | $497 → $606 | Maintains | Market Outperform | |||
11/01/2024 | -16.55% | Guggenheim | $585 → $665 | Maintains | Buy | |||
11/01/2024 | -19.82% | Wells Fargo | $547 → $639 | Maintains | Overweight | |||
11/01/2024 | -22.2% | Piper Sandler | $553 → $620 | Maintains | Overweight | |||
11/01/2024 | -18.94% | Oppenheimer | $560 → $646 | Reiterates | Outperform → Outperform | |||
11/01/2024 | — | William Blair | — | Upgrade | Market Perform → Outperform | |||
11/01/2024 | -22.58% | HC Wainwright & Co. | $533 → $617 | Maintains | Buy | |||
11/01/2024 | -18.44% | Baird | $515 → $650 | Downgrade | Outperform → Neutral | |||
10/31/2024 | -17.18% | Truist Securities | $540 → $660 | Maintains | Buy | |||
10/17/2024 | -20.32% | Citigroup | $512 → $635 | Maintains | Buy | |||
10/10/2024 | -24.08% | Raymond James | → $605 | Reinstates | → Strong Buy | |||
09/26/2024 | -26.59% | Guggenheim | $585 → $585 | Reiterates | Buy → Buy | |||
08/23/2024 | -19.69% | JP Morgan | $500 → $640 | Maintains | Overweight | |||
08/06/2024 | — | Barclays | — | Upgrade | Equal-Weight → Overweight | |||
07/29/2024 | -35.38% | Baird | $490 → $515 | Maintains | Outperform | |||
07/26/2024 | -26.59% | Guggenheim | $545 → $585 | Maintains | Buy | |||
07/26/2024 | -29.73% | Oppenheimer | $546 → $560 | Maintains | Outperform | |||
07/26/2024 | -29.73% | Wedbush | $519 → $560 | Maintains | Outperform | |||
07/26/2024 | -31.36% | Wells Fargo | $543 → $547 | Maintains | Overweight | |||
07/26/2024 | -33.12% | HC Wainwright & Co. | $504 → $533 | Maintains | Buy | |||
07/23/2024 | -31.49% | Oppenheimer | → $546 | Upgrade | Perform → Outperform | |||
07/22/2024 | -32.24% | Truist Securities | $480 → $540 | Maintains | Buy | |||
07/22/2024 | -34.87% | Wedbush | $519 → $519 | Reiterates | Outperform → Outperform | |||
07/17/2024 | -36.76% | HC Wainwright & Co. | $490 → $504 | Maintains | Buy | |||
07/17/2024 | -34.87% | Wedbush | $519 → $519 | Reiterates | Outperform → Outperform | |||
07/12/2024 | -33.12% | Evercore ISI Group | $478 → $533 | Maintains | Outperform | |||
07/01/2024 | -34.87% | Wedbush | $519 → $519 | Reiterates | Outperform → Outperform | |||
06/26/2024 | -34.87% | Wedbush | $519 → $519 | Reiterates | Outperform → Outperform | |||
06/26/2024 | -38.51% | HC Wainwright & Co. | $448 → $490 | Maintains | Buy | |||
06/25/2024 | -39.77% | Truist Securities | $440 → $480 | Maintains | Buy | |||
06/24/2024 | -23.83% | B of A Securities | $535 → $607 | Reiterates | Buy → Buy | |||
06/24/2024 | -37.26% | Stifel | $485 → $500 | Maintains | Buy | |||
06/24/2024 | -32.87% | Piper Sandler | $522 → $535 | Maintains | Overweight | |||
06/24/2024 | -31.99% | Wells Fargo | $478 → $542 | Maintains | Overweight | |||
06/24/2024 | -43.78% | HC Wainwright & Co. | $448 → $448 | Reiterates | Buy → Buy | |||
06/17/2024 | -34.5% | Piper Sandler | $522 → $522 | Maintains | Overweight | |||
06/14/2024 | -43.78% | HC Wainwright & Co. | $448 → $448 | Reiterates | Buy → Buy | |||
05/28/2024 | -36% | Morgan Stanley | $515 → $510 | Maintains | Overweight | |||
05/13/2024 | -37.26% | JP Morgan | $560 → $500 | Maintains | Overweight | |||
05/10/2024 | -43.78% | HC Wainwright & Co. | $451 → $448 | Maintains | Buy | |||
05/10/2024 | -41.27% | JMP Securities | $471 → $468 | Maintains | Market Outperform | |||
04/18/2024 | -34.62% | Wedbush | $521 → $521 | Reiterates | Outperform → Outperform | |||
04/18/2024 | -43.41% | HC Wainwright & Co. | $451 → $451 | Reiterates | Buy → Buy | |||
03/27/2024 | -43.41% | HC Wainwright & Co. | $451 → $451 | Maintains | Buy | |||
03/26/2024 | -48.8% | Scotiabank | $402 → $408 | Maintains | Sector Perform | |||
03/22/2024 | -40.9% | JMP Securities | $471 → $471 | Reiterates | Market Outperform → Market Outperform | |||
03/05/2024 | -44.79% | Truist Securities | $370 → $440 | Maintains | Buy | |||
03/01/2024 | -43.41% | HC Wainwright & Co. | $451 → $451 | Reiterates | Buy → Buy | |||
03/01/2024 | -49.56% | Scotiabank | $346 → $402 | Maintains | Sector Perform | |||
03/01/2024 | -40.9% | JMP Securities | $462 → $471 | Maintains | Market Outperform | |||
03/01/2024 | -38.51% | Baird | $505 → $490 | Maintains | Outperform | |||
02/20/2024 | -40.02% | Wells Fargo | $472 → $478 | Maintains | Overweight | |||
02/15/2024 | — | Wolfe Research | — | Initiates | → Peer Perform | |||
01/26/2024 | -34.5% | Piper Sandler | $518 → $522 | Maintains | Overweight | |||
01/18/2024 | -35% | Piper Sandler | $515 → $518 | Maintains | Overweight | |||
12/21/2023 | -45.29% | Evercore ISI Group | $594 → $436 | Maintains | Outperform | |||
12/21/2023 | -56.58% | Scotiabank | $444 → $346 | Maintains | Sector Perform |
L'ultimo obiettivo di prezzo per argenx (NASDAQ:ARGX) è stato riportato da {{analyst} in data {{date}}. La società di analisi ha fissato un obiettivo di prezzo per $1040.00 prevedendo che ARGX raggiunga rise entro 12 mesi (un possibile 30.50% upside).
L'ultima valutazione degli analisti per argenx (NASDAQ:ARGX) è stato fornita da Morgan Stanley e argenx mantenuto il suo rating overweight.
L'ultima revisione al rialzo di argenx SE è avvenuta il maggio 13, 2025, quando Baird ha alzato il suo obiettivo di prezzo a $680. In precedenza Baird aveva a neutral per argenx SE.
L'ultima revisione al ribasso di argenx SE si è verificata il novembre 1, 2024, quando Baird ha modificato il suo obiettivo di prezzo da $515 a $650 per argenx SE.
Gli analisti giungono alle valutazioni dei titoli dopo aver fatto ricerche approfondite, che comprendono l'esame dei bilanci pubblici, i colloqui con i dirigenti e i clienti di argenx e l'ascolto delle comunicazioni degli utili. La maggior parte degli analisti svolge questa attività ogni tre mesi, quindi dovresti ricevere 4 valutazioni all'anno per azienda e per società. L'ultima valutazione di argenx è stata depositata il ottobre 1, 2025, quindi dovresti aspettarti che la prossima valutazione sia disponibile intorno a ottobre 1, 2026.
Sebbene le valutazioni siano soggettive e possano cambiare, l'ultima valutazione di argenx (ARGX) è stata una mantenuto con un obiettivo di prezzo di $766.00 a $1040.00. Il prezzo attuale a cui argenx (ARGX) è scambiato è $796.92, che è within del range previsto dall'analista.
Sfoglia valutazioni degli analisti e obiettivi di prezzo su tutte le azioni.